Maisa Feghali

Summary

Publications

  1. doi request reprint Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations
    Maisa Feghali
    Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA Electronic address
    Semin Perinatol 38:516-22. 2014
  2. doi request reprint Preterm induction of labor: predictors of vaginal delivery and labor curves
    Maisa Feghali
    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Magee Womens Hospital of UPMC, University of Pittsburgh, Pittsburgh, PA Electronic address
    Am J Obstet Gynecol 212:91.e1-7. 2015
  3. pmc Clinical therapeutics in pregnancy
    Maisa N Feghali
    Department of Obstetrics and Gynecology, Washington Hospital Center, Washington, DC 20010, USA
    J Biomed Biotechnol 2011:783528. 2011
  4. doi request reprint Association of vaginal delivery efforts with retinal disease in women with type I diabetes
    Maisa Feghali
    Department of Obstetrics and Gynecology, Washington Hospital Center, Washington, DC 20010, USA
    J Matern Fetal Neonatal Med 25:27-31. 2012
  5. doi request reprint Asymmetric large for gestational age newborns in pregnancies complicated by diabetes mellitus: is maternal obesity a culprit?
    Maisa N Feghali
    Department of Obstetrics and Gynecology, Washington Hospital Center, MedStar Health, Washington DC, USA
    J Matern Fetal Neonatal Med 25:32-5. 2012
  6. doi request reprint Rates of recurrent preterm birth by maternal body habitus in women receiving 17α-hydroxyprogesterone caproate
    Julia Timofeev
    Department of Obstetrics and Gynecology, MedStar Health Washington Hospital Center, Washington, DC, USA
    J Matern Fetal Neonatal Med 26:881-4. 2013

Detail Information

Publications6

  1. doi request reprint Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations
    Maisa Feghali
    Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA Electronic address
    Semin Perinatol 38:516-22. 2014
    ..We will also discuss pharmacokinetic and pharmacodynamics data to highlight drug metabolism and mechanism of action, which will help clarify the variability in clinical outcomes and efficacy. ..
  2. doi request reprint Preterm induction of labor: predictors of vaginal delivery and labor curves
    Maisa Feghali
    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Magee Womens Hospital of UPMC, University of Pittsburgh, Pittsburgh, PA Electronic address
    Am J Obstet Gynecol 212:91.e1-7. 2015
    ..The purpose of this study was to evaluate the labor curves of patients who undergo preterm induction of labor (IOL) and to assess possible predictors of vaginal delivery (VD)...
  3. pmc Clinical therapeutics in pregnancy
    Maisa N Feghali
    Department of Obstetrics and Gynecology, Washington Hospital Center, Washington, DC 20010, USA
    J Biomed Biotechnol 2011:783528. 2011
    ....
  4. doi request reprint Association of vaginal delivery efforts with retinal disease in women with type I diabetes
    Maisa Feghali
    Department of Obstetrics and Gynecology, Washington Hospital Center, Washington, DC 20010, USA
    J Matern Fetal Neonatal Med 25:27-31. 2012
    ..Progression of DR during pregnancy and between pregnancy and postpartum was compared among the groups...
  5. doi request reprint Asymmetric large for gestational age newborns in pregnancies complicated by diabetes mellitus: is maternal obesity a culprit?
    Maisa N Feghali
    Department of Obstetrics and Gynecology, Washington Hospital Center, MedStar Health, Washington DC, USA
    J Matern Fetal Neonatal Med 25:32-5. 2012
    ..Evaluate the association between body mass index (BMI) and the delivery of an asymmetrically large for gestational age (A-LGA) newborn in women with diabetes...
  6. doi request reprint Rates of recurrent preterm birth by maternal body habitus in women receiving 17α-hydroxyprogesterone caproate
    Julia Timofeev
    Department of Obstetrics and Gynecology, MedStar Health Washington Hospital Center, Washington, DC, USA
    J Matern Fetal Neonatal Med 26:881-4. 2013
    ..To examine the influence of maternal pre-pregnancy body mass index (BMI) on the rates of recurrent spontaneous preterm birth (SPTB) in women receiving 17α-hydroxyprogesterone caproate (17P)...